Gastrointestinal effects such as nausea, early satiety, and changes in bowel habits are common, though typically transient and improved with gradual dose titration [30]
Novel object recognition test in rats co-treated with BSO and GBR 12909 The novel object recognition test in rats co-treated with BSO and GBR12909 was assessed at 91 days of age ( Fig
If you carry an unfavorable GIPR tolerability variant, you may experience more nausea on this drug than on a GLP-1-only conjugate
Together, well delve into the various aspects of GLP-1 drugs, including their classifications, the significance of the recent FDA approvals, and the potential benefits they offer
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial
Research studies have demonstrated its potential benefits for weight loss, particularly when combined with a balanced diet and regular exercise